Detalhe da pesquisa
1.
Evaluation of an EZH2 inhibitor in patient-derived orthotopic xenograft models of pediatric brain tumors alone and in combination with chemo- and radiation therapies.
Lab Invest
; 102(2): 185-193, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34802040
2.
Synergistic anti-tumor efficacy of mutant isocitrate dehydrogenase 1 inhibitor SYC-435 with standard therapy in patient-derived xenograft mouse models of glioma.
Transl Oncol
; 18: 101368, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35182954
3.
ZFTA-RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma.
Cancer Discov
; 11(9): 2200-2215, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741710
4.
Patient-Derived Orthotopic Xenograft (PDOX) Mouse Models of Primary and Recurrent Meningioma.
Cancers (Basel)
; 12(6)2020 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32517016
5.
Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition.
JCO Precis Oncol
; 42020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923898
6.
Concurrent Inhibition of Neurosphere and Monolayer Cells of Pediatric Glioblastoma by Aurora A Inhibitor MLN8237 Predicted Survival Extension in PDOX Models.
Clin Cancer Res
; 24(9): 2159-2170, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29463553
7.
Xenotransplantation of pediatric low grade gliomas confirms the enrichment of BRAF V600E mutation and preservation of CDKN2A deletion in a novel orthotopic xenograft mouse model of progressive pleomorphic xanthoastrocytoma.
Oncotarget
; 8(50): 87455-87471, 2017 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29152094